PROPANC BIOPHARMA INC
PPCB · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $0.44
- Today’s Low
- $0.41
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.48
- Previous Close
- $0.44
- Volume
- 199.39K
- Market Cap
- $4.54M
- P/E Ratio
- --
- EPS
- $-25.66
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 302, 6 BUTLER STREET, CAMBERWELL, VIC, AUSTRALIA, 3124
- Country
- AU
- Listing Date
- 2012-06-15
- Fiscal Year End
- June
- Shares Outstanding
- 2.28M
- CIK
- 0001517681
- Website
- www.propanc.com
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. The company is headquartered in Camberwell, Australia.
Financial Metrics
Revenue
2026-06-30
--
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.45M
2026-03-31
$6.4M
2025-12-31
$3.65M
2025-09-30
$4.67M
Net Income
2026-06-30
-$4.57M
2026-03-31
-$6.36M
2025-12-31
-$3.09M
2025-09-30
-$4.83M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
$-0.39
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.45M
2026-03-31
-$6.31M
2025-12-31
-$3.02M
2025-09-30
-$4.52M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | -- | $0 | $0 | $0 |
| Operating Expenses | $3.45M | $6.4M | $3.65M | $4.67M |
| Net Income | -$4.57M | -$6.36M | -$3.09M | -$4.83M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | -- | -- | -- | $-0.39 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.45M | -$6.31M | -$3.02M | -$4.52M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.